背景:目前建议将小腿周长作为肌少症的病例发现标记,但其在慢性疼痛条件下的有效性尚未确定。因此,本研究旨在评估小腿围在诊断老年慢性下腰痛患者少肌症中的预测性能。
方法:纳入年龄≥65岁患有慢性下腰痛的非卧床成人患者。根据亚洲肌肉减少症工作组在2019年概述的标准确定了肌肉减少症的诊断。患者人口统计学,疼痛相关因素,临床因素,并比较了非肌少症患者和肌少症患者的肌少症相关测量结果。采用线性回归分析评价小腿围与肌肉质量的相关性,力量,和物理性能。此外,进行了预测肌肉减少症的小腿围的受试者工作特征曲线分析;和曲线下面积(AUC)值,以及它们相应的95%置信区间(CI),被计算。
结果:分析中纳入了592例患者的数据。85例患者被诊断为肌肉减少症(14.3%),其中71例患有重度肌少症(11.9%)。女性患者的肌肉减少症患病率较高(9.0%vs.16.7%,p=0.016)。在调整了年龄之后,BMI,和合并症,小腿周长与肌肉质量呈正相关,但与肌肉力量和身体表现无关。男性肌肉减少症的AUC值为0.754(95%CI=0.636-0.871,p=0.001),女性为0.721(95%CI=0.657-0.786,p<0.001)。预测肌少症的小腿围的临界值为34cm(敏感性为67.1%,特异性70.6%)在男性中,和31厘米(灵敏度82.5%,特异性51.5%)在女性中。
结论:尽管对肌少症的预测价值存在性别差异,我们的研究结果表明,小腿围可以作为预测肌肉质量的指标,也可以作为识别老年慢性下腰痛患者肌肉减少症的潜在标志.
BACKGROUND: Calf circumference is currently recommended as a case-finding marker for sarcopenia, but its usefulness has not been determined in chronic pain conditions. Therefore, the present study aimed to evaluate the predictive performance of calf circumference in diagnosing sarcopenia in older patients with chronic low back pain.
METHODS: Ambulatory adult patients aged ≥ 65 years with chronic low back pain were enrolled. A diagnosis of sarcopenia was established based on the criteria outlined by the Asian Working Group for Sarcopenia in 2019. Patient demographics, pain-related factors, clinical factors, and sarcopenia-related measurements were compared between non-sarcopenic and sarcopenic patients. Linear regression analysis was used to evaluate the correlation of calf circumference with muscle mass, strength, and physical performance. Also, a receiver operating characteristic curve analysis for calf circumference in predicting sarcopenia was conducted; and area under the curve (AUC) values, along with their corresponding 95% confidence intervals (CI), were calculated.
RESULTS: Data from 592 patients were included in the analysis. Eighty-five patients were diagnosed with sarcopenia (14.3%), 71 of whom had severe sarcopenia (11.9%). A higher prevalence of sarcopenia was observed in female patients (9.0% vs. 16.7%, p = 0.016). After adjusting for age, BMI, and comorbidities, calf circumference correlated positively with muscle mass but not with muscle strength and physical performance. The AUC values for sarcopenia were 0.754 (95% CI = 0.636-0.871, p = 0.001) in males and 0.721 (95% CI = 0.657-0.786, p < 0.001) in females. The cut-offs for calf circumference in predicting sarcopenia were 34 cm (sensitivity 67.1%, specificity 70.6%) in males, and 31 cm (sensitivity 82.5%, specificity 51.5%) in females.
CONCLUSIONS: Even though sex differences in its predictive value for sarcopenia should be considered, our findings suggest that calf circumference can be used as an indicator for predicting muscle mass and may serve as a potential marker for identifying sarcopenia in older patients with chronic low back pain.